Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (893)	11/11/1998 12:46:00 PM
From: Blitz	Read Replies (2) \| Respond to of 1286

Here's a REAL company WITH EPA approval (BSNS WIRE) Tejas Securities Group Issues Initial Investment Recommendat Tejas Securities Group Issues Initial Investment Recommendation of BioShield Technologies Business Editors NOTE TO EDITORS: The following is an investment opinion issued by Tejas Securites Group AUSTIN, Texas--(BUSINESS WIRE)--Nov. 11, 1998--BioShield Technologies Inc.'s (NASDAQ:BSTIU) recent product approval from the EPA, the attractive characteristics of its proprietary antimicrobial molecule, and its product additive revenue model has prompted Tejas Securities analyst Blake Carter to issue a BUY recommendation in his initial report on the company. "EPA approval of BioShield's core-active products marks the beginning of the company's emergence from development stage status," said Carter. "While BioShield is a speculative investment, the potential upside is exciting." BioShield Technologies Inc.'s IPO of 650,000 units was managed by Tejas Securities in September. BioShield's proprietary molecule combines water-based antimicrobial technology with non-leaching, non-ingesting and convalent-bonding properties, making it a versatile additive for killing not only bacteria on contact, but also viruses, fungi, algae, yeast and other microbes. BioShield is currently marketed through several retail outlets including grocery stores and the QVC home shopping network. It is the company's new product additive business model that has the potential the potential to add substantial value to BioShield's equity, according to Carter. Use as an additive in textiles, cosmetics, plastics, pharmaceuticals and others products could open the door to significant revenue. "The scores of potential applications for BioShield's core-active ingredient provide upside potential that is very exciting, especially in light of BioShield's current $17 million equity valuation," noted Carter. "We are not just excited about BioShield because of its top-line potential, we are also excited because of the high profit margins associated with many of the business segments the company is entering." Tejas Securities Company was founded in 1994 and offers investment banking, initial public offerings of common and preferred stock, equities, high yield bonds and other investment products. The securities discussed in this release are speculative and may not be appropriate for all investors. For more information or a complete research report on BioShield Technologies Inc., contact Tejas Securities Group at 800/846-6803. --30--ec/sa* CONTACT: Tejas Securities Company, Austin Blake Carter, 800/846-6803 KEYWORD: TEXAS INDUSTRY KEYWORD: MD Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *